Oxidation of CaMKII determines the cardiotoxic effects of aldosterone

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Pathophysiology

Background:

• Neurohumoral pathways, including beta-adrenergic, angiotensin II (Ang II), and aldosterone signaling, are implicated in post-myocardial infarction (MI) mortality.
• Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is activated by catecholamines and Ang II, and its inhibition protects against related cardiomyopathies.

Purpose of the Study:

• To investigate the direct cardiotoxic effects of aldosterone on the myocardium following myocardial infarction.
• To elucidate the role of CaMKII oxidation in mediating aldosterone-induced cardiac damage and mortality.

Main Methods:

• Utilized a mouse model of myocardial infarction.
• Investigated aldosterone's effects on CaMKII oxidation, NADPH oxidase activity, and matrix metalloproteinase 9 (MMP9) expression in cardiomyocytes.
• Assessed the impact of CaMKII inhibition, methionine sulfoxide reductase A overexpression, and NADPH oxidase deficiency on cardiac rupture and mortality.

Main Results:

• Aldosterone directly causes cardiotoxicity through oxidative activation of CaMKII, leading to cardiac rupture and increased mortality post-MI.
• Aldosterone promotes CaMKII oxidation by recruiting NADPH oxidase, which in turn enhances MMP9 expression in cardiomyocytes.
• Interventions targeting CaMKII oxidation (inhibition, MSR A overexpression, NADPH oxidase deficiency) effectively prevented aldosterone-induced cardiac rupture.

Conclusions:

• Oxidized myocardial CaMKII is a key mediator of aldosterone's cardiotoxic effects on the cardiac matrix.
• CaMKII serves as a central signaling node for neurohumoral pathways contributing to adverse outcomes after myocardial infarction.